2017 Q3 Form 10-Q Financial Statement
#000156459017022650 Filed on November 08, 2017
Income Statement
| Concept | 2017 Q3 | 2016 Q3 |
|---|---|---|
| Revenue | $190.2M | $177.5M |
| YoY Change | 7.15% | -3.27% |
| Cost Of Revenue | $36.20M | $34.30M |
| YoY Change | 5.54% | 11.0% |
| Gross Profit | $154.0M | $143.2M |
| YoY Change | 7.54% | -6.16% |
| Gross Profit Margin | 80.97% | 80.68% |
| Selling, General & Admin | $107.2M | $111.9M |
| YoY Change | -4.2% | 29.36% |
| % of Gross Profit | 69.61% | 78.14% |
| Research & Development | $17.80M | $19.40M |
| YoY Change | -8.25% | 12.79% |
| % of Gross Profit | 11.56% | 13.55% |
| Depreciation & Amortization | $3.900M | $3.700M |
| YoY Change | 5.41% | 2.78% |
| % of Gross Profit | 2.53% | 2.58% |
| Operating Expenses | $125.0M | $131.3M |
| YoY Change | -4.8% | 26.62% |
| Operating Profit | $84.00M | $7.100M |
| YoY Change | 1083.1% | -83.6% |
| Interest Expense | $900.0K | $700.0K |
| YoY Change | 28.57% | 600.0% |
| % of Operating Profit | 1.07% | 9.86% |
| Other Income/Expense, Net | -$800.0K | -$2.200M |
| YoY Change | -63.64% | -1200.0% |
| Pretax Income | $83.20M | $4.900M |
| YoY Change | 1597.96% | -88.74% |
| Income Tax | $4.500M | $5.600M |
| % Of Pretax Income | 5.41% | 114.29% |
| Net Earnings | $78.80M | -$700.0K |
| YoY Change | -11357.14% | -102.31% |
| Net Earnings / Revenue | 41.43% | -0.39% |
| Basic Earnings Per Share | $1.15 | -$0.01 |
| Diluted Earnings Per Share | $1.12 | -$0.01 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 68.60M | 68.80M |
| Diluted Shares Outstanding | 70.40M | 68.80M |
Balance Sheet
| Concept | 2017 Q3 | 2016 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $148.3M | $148.4M |
| YoY Change | -0.07% | -4.5% |
| Cash & Equivalents | $87.90M | $86.90M |
| Short-Term Investments | $60.40M | $61.50M |
| Other Short-Term Assets | $18.30M | $17.80M |
| YoY Change | 2.81% | -45.4% |
| Inventory | $38.90M | $53.90M |
| Prepaid Expenses | ||
| Receivables | $113.2M | $98.20M |
| Other Receivables | $6.900M | $4.600M |
| Total Short-Term Assets | $325.6M | $322.9M |
| YoY Change | 0.84% | 5.08% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $49.80M | $56.80M |
| YoY Change | -12.32% | -12.48% |
| Goodwill | $312.8M | |
| YoY Change | 76.42% | |
| Intangibles | $521.2M | |
| YoY Change | 175.18% | |
| Long-Term Investments | $50.10M | $52.20M |
| YoY Change | -4.02% | 21.11% |
| Other Assets | $5.000M | |
| YoY Change | 0.0% | |
| Total Long-Term Assets | $902.7M | $948.0M |
| YoY Change | -4.78% | 97.62% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $325.6M | $322.9M |
| Total Long-Term Assets | $902.7M | $948.0M |
| Total Assets | $1.228B | $1.271B |
| YoY Change | -3.35% | 61.49% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $22.50M | $19.90M |
| YoY Change | 13.07% | 25.95% |
| Accrued Expenses | $37.20M | $54.80M |
| YoY Change | -32.12% | 31.1% |
| Deferred Revenue | $2.900M | |
| YoY Change | ||
| Short-Term Debt | $0.00 | $200.0M |
| YoY Change | -100.0% | |
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $139.2M | $274.9M |
| YoY Change | -49.36% | 365.93% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $74.20M | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $7.400M | $1.100M |
| YoY Change | 572.73% | -50.0% |
| Total Long-Term Liabilities | $7.400M | $1.100M |
| YoY Change | 572.73% | -50.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $139.2M | $274.9M |
| Total Long-Term Liabilities | $7.400M | $1.100M |
| Total Liabilities | $357.4M | $535.6M |
| YoY Change | -33.27% | 436.14% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$86.50M | |
| YoY Change | 9.77% | |
| Common Stock | $827.6M | |
| YoY Change | 7.06% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $870.9M | $735.5M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $1.228B | $1.271B |
| YoY Change | -3.35% | 61.49% |
Cashflow Statement
| Concept | 2017 Q3 | 2016 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $78.80M | -$700.0K |
| YoY Change | -11357.14% | -102.31% |
| Depreciation, Depletion And Amortization | $3.900M | $3.700M |
| YoY Change | 5.41% | 2.78% |
| Cash From Operating Activities | $23.50M | -$2.900M |
| YoY Change | -910.34% | -109.73% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$1.600M | -$1.500M |
| YoY Change | 6.67% | 50.0% |
| Acquisitions | $213.0M | |
| YoY Change | ||
| Other Investing Activities | -$13.60M | -$156.5M |
| YoY Change | -91.31% | -1665.0% |
| Cash From Investing Activities | -$15.20M | -$158.0M |
| YoY Change | -90.38% | -1855.56% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $21.30M | |
| YoY Change | -43.95% | |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -23.30M | 175.8M |
| YoY Change | -113.25% | -1256.58% |
| NET CHANGE | ||
| Cash From Operating Activities | 23.50M | -2.900M |
| Cash From Investing Activities | -15.20M | -158.0M |
| Cash From Financing Activities | -23.30M | 175.8M |
| Net Change In Cash | -15.00M | 14.90M |
| YoY Change | -200.67% | -36.86% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $23.50M | -$2.900M |
| Capital Expenditures | -$1.600M | -$1.500M |
| Free Cash Flow | $25.10M | -$1.400M |
| YoY Change | -1892.86% | -104.55% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
84400000 | |
| CY2017Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
0 | |
| CY2017Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
84400000 | |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
190200000 | |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
177500000 | |
| CY2017Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
36200000 | |
| CY2016Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
34300000 | |
| CY2017Q3 | mygn |
Cost Of Pharmaceutical And Clinical Services
CostOfPharmaceuticalAndClinicalServices
|
6800000 | |
| CY2016Q3 | mygn |
Cost Of Pharmaceutical And Clinical Services
CostOfPharmaceuticalAndClinicalServices
|
5700000 | |
| CY2017Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
17800000 | |
| CY2016Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
19400000 | |
| CY2017Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-73200000 | |
| CY2016Q3 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
500000 | |
| CY2017Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
115200000 | |
| CY2016Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
111900000 | |
| CY2017Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
102800000 | |
| CY2016Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
171800000 | |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
87400000 | |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5700000 | |
| CY2017Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
400000 | |
| CY2016Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
300000 | |
| CY2017Q3 | us-gaap |
Interest Expense
InterestExpense
|
900000 | |
| CY2016Q3 | us-gaap |
Interest Expense
InterestExpense
|
700000 | |
| CY2017Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-300000 | |
| CY2016Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1300000 | |
| CY2017Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-800000 | |
| CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1700000 | |
| CY2017Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
86600000 | |
| CY2016Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
4000000 | |
| CY2017Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5600000 | |
| CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5200000 | |
| CY2017Q3 | us-gaap |
Profit Loss
ProfitLoss
|
81000000 | |
| CY2016Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-1200000 | |
| CY2017Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-100000 | |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
81100000 | |
| CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
2700000 | |
| CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
0 | |
| CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1200000 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.18 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.15 | |
| CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
68600000 | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
68800000 | |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
70400000 | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
68800000 | |
| CY2016Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-400000 | |
| CY2017Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
3300000 | |
| CY2016Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
4300000 | |
| CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
2700000 | |
| CY2017Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
13200000 | |
| CY2016Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
9200000 | |
| CY2017Q3 | mygn |
Non Cash Interest Expense
NonCashInterestExpense
|
100000 | |
| CY2016Q3 | mygn |
Non Cash Interest Expense
NonCashInterestExpense
|
100000 | |
| CY2017Q3 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
100000 | |
| CY2016Q3 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
200000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6400000 | |
| CY2016Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7800000 | |
| CY2017Q3 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
8000000 | |
| CY2016Q3 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
7200000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-4700000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-3200000 | |
| CY2017Q3 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
6700000 | |
| CY2016Q3 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
400000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-3200000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-7800000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
16500000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5900000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-300000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
1800000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-3300000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
13000000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
8900000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
1000000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
400000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-5000000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-5800000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-10000000 | |
| CY2017Q3 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
600000 | |
| CY2016Q3 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1000000 | |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
23500000 | |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2900000 | |
| CY2017Q3 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
1600000 | |
| CY2016Q3 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
1500000 | |
| CY2016Q3 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
213000000 | |
| CY2017Q3 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
31500000 | |
| CY2016Q3 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
32200000 | |
| CY2017Q3 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
17900000 | |
| CY2016Q3 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
88700000 | |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-15200000 | |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-158000000 | |
| CY2017Q3 | mygn |
Proceeds From Repayments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromRepaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
1700000 | |
| CY2016Q3 | mygn |
Proceeds From Repayments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromRepaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
-1900000 | |
| CY2016Q3 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
199000000 | |
| CY2017Q3 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
25000000 | |
| CY2016Q3 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
21300000 | |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-23300000 | |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
175800000 | |
| CY2017Q3 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
500000 | |
| CY2016Q3 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
3500000 | |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-14500000 | |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
18400000 | |
| CY2016Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
68500000 | |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
86900000 | |
| CY2017Q3 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td> <td valign="top"> <p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">BASIS OF PRESENTATION</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the “Company” or “Myriad”) in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2017, included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017. Operating results for the three months ended September 30, 2017 may not necessarily be indicative of results to be expected for any other interim period or for the full year.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements include the accounts of the Company’s majority-owned subsidiary, Assurex Canada, Ltd. which is 85% owned by Assurex Health, Inc. (“Assurex”), a wholly owned subsidiary of the Company, and 15% owned by the Centre for Addiction and Mental Health. Assurex Canada, Ltd. is a consolidated subsidiary of Assurex Health, Inc. The value of the non-controlling interest represents the portion of Assurex Canada, Ltd.’s profit or loss and net assets that is not held by Assurex Health, Inc. The Company attributes comprehensive income or loss of the subsidiary between the Company and the non-controlling interest based on the respective ownership interest.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Immaterial error correction to consolidated statements of operations</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the preparation of the financial statements for the quarter ended September 30, 2017, the Company determined that the amounts for the change in the fair value of contingent consideration were improperly reported as a component of other income (expense) and should have been reported as a component of operating income on the consolidated statements of operations at September 30, 2016. As a result, total costs and expenses and operating income were understated by $0.5 and other income (expense) and total other income were overstated $0.5. There was no impact to Net Income or earnings per share. The Company concluded that the error was not material to the consolidated statements of operations, but has elected to correct the error in the accompanying financial statements for consistent presentation. The classification error had no effect on the on the previously reported consolidated balance sheets, statements of comprehensive income or cash flows for the quarter ended September 30, 2016.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">New Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued Accounting Standards Update 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will be effective beginning in the first quarter of fiscal 2019. Early adoption of ASU 2016-02 is permitted. ASU 2016-02 requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. The Company’s management is currently evaluating the impact of adopting ASU 2016-02 on the Company’s consolidated financial statements.</p> <p style="margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2014, the Financial Accounting Standards Board (FASB) issued the converged standard on revenue recognition with the objective of providing a single, comprehensive model for all contracts with customers to improve comparability in the financial statements of companies reporting using International Financial Reporting Standards and U.S. GAAP. The standard contains principles that an entity must apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity must recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. An entity can apply the revenue standard retrospectively to each prior reporting period presented (full retrospective method) or retrospectively with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings (modified retrospective method). The standard will be effective for the Company first quarter of fiscal 2019, with early adoption permitted for annual periods beginning after December 16, 2016. The Company plans to adopt the standard July 1, 2018 using the full retrospective method. The Company continues to assess the impact of this standard on its results of operations, financial position and cash flows. Based on its preliminary assessment, the Company expects the majority of the amounts that have historically been classified as bad debt expense, primarily related to patient responsibility, will be reflected as a reduction of the transaction price and therefore as a reduction in revenue. The Company anticipates an increase in the level of required financial statement disclosures due to the standard.</p></div> | |
| CY2017Q3 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
100000 | |
| CY2017Q3 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
1.18 | |
| CY2016Q3 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
|
-0.28 | |
| CY2017Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
100900000 | |
| CY2017Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
97300000 | |
| CY2017Q3 | us-gaap |
Depreciation
Depreciation
|
3900000 | |
| CY2017Q3 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
|
1.15 | |
| CY2016Q3 | us-gaap |
Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
|
-800000 | |
| CY2017Q3 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
81100000 | |
| CY2016Q3 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-19200000 | |
| CY2016Q3 | us-gaap |
Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
|
-0.28 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
198400000 | |
| CY2017Q3 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
100000 | |
| CY2017Q3 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
190200000 | |
| CY2016Q3 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
188900000 | |
| CY2017Q3 | us-gaap |
Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
|
87400000 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
198400000 | |
| CY2017Q3 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
198400000 | |
| CY2017Q3 | mygn |
Investments And Cash At Fair Value
InvestmentsAndCashAtFairValue
|
198400000 | |
| CY2017Q2 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
199300000 | |
| CY2017Q2 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
100000 | |
| CY2017Q2 | us-gaap |
Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
200000 | |
| CY2017Q2 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
199200000 | |
| CY2017Q2 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
199300000 | |
| CY2017Q2 | mygn |
Investments And Cash At Fair Value
InvestmentsAndCashAtFairValue
|
199200000 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
60400000 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
50100000 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
0 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
60400000 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
50100000 | |
| CY2017Q3 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
0 | |
| CY2017Q3 | us-gaap |
Land
Land
|
2400000 | |
| CY2017Q2 | us-gaap |
Land
Land
|
2300000 | |
| CY2017Q3 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
17500000 | |
| CY2017Q2 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
17100000 | |
| CY2017Q3 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
22100000 | |
| CY2017Q2 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
22100000 | |
| CY2017Q3 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
108700000 | |
| CY2017Q2 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
106900000 | |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
150700000 | |
| CY2017Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
148400000 | |
| CY2016Q3 | us-gaap |
Depreciation
Depreciation
|
3700000 | |
| CY2017Q3 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
900000 | |
| CY2017Q2 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
900000 | |
| CY2017Q3 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
6100000 | |
| CY2017Q2 | us-gaap |
Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
5900000 | |
| CY2017Q3 | mygn |
Other Liabilities Noncurrent Other
OtherLiabilitiesNoncurrentOther
|
1300000 | |
| CY2017Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
37200000 | |
| CY2017Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
44400000 | |
| CY2017Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
8600000 | |
| CY2017Q2 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
7100000 | |
| CY2017Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
14000000 | |
| CY2017Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
14100000 | |
| CY2017Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
75100000 | |
| CY2017Q2 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
100000000 | |
| CY2017Q3 | us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
1900000 | |
| CY2017Q3 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
1000000 | |
| CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
534400000 | |
| CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
74300000 | |
| CY2017Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
460100000 | |
| CY2017Q3 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
23700000 | |
| CY2017Q3 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
558100000 | |
| CY2017Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
533300000 | |
| CY2017Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
64800000 | |
| CY2017Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
468500000 | |
| CY2017Q2 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
23100000 | |
| CY2017Q2 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
556400000 | |
| CY2017Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9300000 | |
| CY2016Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5500000 | |
| CY2017Q2 | mygn |
Other Liabilities Noncurrent Other
OtherLiabilitiesNoncurrentOther
|
1300000 | |
| CY2017Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
7400000 | |
| CY2017Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
7200000 | |
| CY2017Q3 | mygn |
Number Of Defined Benefit Pension Plans
NumberOfDefinedBenefitPensionPlans
|
2 | |
| CY2017Q3 | us-gaap |
Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
|
100000 | |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
| CY2017Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
| CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
69200000 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
68400000 | |
| CY2016Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
69100000 | |
| CY2016Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
69100000 | |
| CY2017Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
800000 | |
| CY2016Q3 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
300000 | |
| CY2016Q3 | us-gaap |
Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
|
1000000 | |
| CY2016Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
68400000 | |
| CY2016Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
68400000 | |
| CY2017Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1800000 | |
| CY2017Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1500000 | |
| CY2016Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9600000 | |
| CY2017Q3 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
160700000 | |
| CY2016Q3 | mygn |
Amount Of Reduction In Common Stock As Result Of Stock Repurchases
AmountOfReductionInCommonStockAsResultOfStockRepurchases
|
9100000 | |
| CY2016Q3 | mygn |
Amount Charged To Retained Earnings As Result Of Stock Repurchases
AmountChargedToRetainedEarningsAsResultOfStockRepurchases
|
12200000 | |
| CY2017Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.065 | |
| CY2016Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
1.300 | |
| CY2017Q3 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
|
Options and restricted stock units granted to our non-employee directors vest in full upon completion of one year of service on the Board following the date of the grant. | |
| CY2017Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
8000000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
0 | |
| CY2017Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
400000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
100000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
7500000 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
7500000 | |
| CY2017Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
24.67 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
22.75 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
26.56 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
24.77 | |
| CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
24.77 | |
| CY2017Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
0 | |
| CY2017Q3 | us-gaap |
Fair Value Net Asset Liability
FairValueNetAssetLiability
|
48300000 | |
| CY2017Q2 | us-gaap |
Fair Value Net Asset Liability
FairValueNetAssetLiability
|
-24800000 | |
| CY2017Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
140500000 | |
| CY2017Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-73200000 | |
| CY2017Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
|
500000 | |
| CY2017Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
67800000 | |
| CY2017Q3 | mygn |
Percent Of Employee Contribution To Deferred Savings Plan
PercentOfEmployeeContributionToDeferredSavingsPlan
|
0.50 | |
| CY2017Q3 | mygn |
Employers Contribution Not To Exceed Percentage Of Employees Compensation
EmployersContributionNotToExceedPercentageOfEmployeesCompensation
|
0.04 | |
| CY2017Q3 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
1900000 | |
| CY2016Q3 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
1600000 | |
| CY2017Q3 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | |
| CY2017Q3 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
5200000 | |
| CY2016Q3 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
3300000 | |
| CY2016Q3 | us-gaap |
Assets Fair Value Adjustment
AssetsFairValueAdjustment
|
-400000 |
